Back to Search
DR. PHILIP HOLLANDER D.O.
D.O.
Family Medicine Physician
NPI: 1831128370Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
25MB02316000(NJ)
Research & Publications (20)
Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
PMID 18824271·Diabetes Res Clin Pract·2008
2-rct
A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
PMID 19108786·Clin Ther·2008
4-observational
Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.
PMID 18364392·Diabetes Care·2008
4-observational
Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.
PMID 18535196·Diabetes Care·2008
2-rct
SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes.
PMID 18678611·Diabetes Care·2008
2-rct
Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus.
PMID 17296341·Am J Med·2007
4-observational
A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients.
PMID 17363756·Diabetes Care·2007
4-observational
Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes.
PMID 17435648·MedGenMed·2007
6-review
Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials.
PMID 17536080·Diabetes Care·2007
3-trial
Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes.
PMID 17592102·Arch Intern Med·2007
4-observational
Basal insulin or premix analogue therapy in type 2 diabetes patients.
PMID 17223044·Eur J Intern Med·2007
8-other
Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) interacts with PELP1 and activates MAPK.
PMID 16352611·J Biol Chem·2006
7-preclinical
Training with inspiratory pressure support in patients with severe COPD.
PMID 16387937·Eur Respir J·2006
2-rct
Effectiveness of diabetes resource nurse case management and physician profiling in a fee-for-service setting: a cluster randomized trial.
PMID 16609732·Proc (Bayl Univ Med Cent)·2006
8-other
Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults.
PMID 17011500·Cell Metab·2006
4-observational
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.
PMID 17098084·Lancet·2006
4-observational
Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.
PMID 15677776·Diabetes Care·2005
3-trial
Quadriceps muscle endurance in patients with chronic obstructive pulmonary disease.
PMID 14755493·Muscle Nerve·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 103 OLD MARLTON PIKE, SUITE 103
MEDFORD, NJ 08055 - Phone
- (609) 953-7105
Quick Facts
- NPI
- 1831128370
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile